The University released the following emails regarding the selection of its eighth president July 13 at the request of the Richmond Times-Dispatch. The emails include a message from Gordon Rainey, an alumni representative on the Search Committee and the director of the Capital Campaign, summarizing an interview with an individual who suggested “if we do not find Mr. or Mrs. Perfect…hire someone for the interim (4-6 years) to be a change agent with a view to picking someone after that to serve for 10-15 years.”
University Records Officer Caroline Walters made the following notations regarding legal exemptions from the released documents:
“Please note that one document was removed as entirely exempt (this removal is specifically noted on the email to which that document was attached.) All other documents actually attached to this set of emails were reviewed and they have been provided to you, in several cases with personal identifying information minimally redacted. However, you will likely note that all of the emails have a footer suggesting that an “attachment” was present. I wanted to let you know that the “attachment” footer in most cases is an artifact of the conversion of these records to the electronic system we are using for review of these FOIA requests. Therefore please do not be surprised at the relatively small number of attachments you will actually see here”
Read More
A look at the past, present and future renovations of the Academical Village
By Brandon Kile | 2 days agoUNESCO selected the Academical Village to be inducted as a World Heritage Site in 1987, making it the only American university to hold the honor.
University advances sustainability goals outlined in 2030 Plan
By Vyshnavi Tatta | 5 days agoAs part of the 2030 Plan’s goal to reach carbon neutrality by 2030 and fossil fuel-free operations by 2050, the University has prioritized environmental resilience and sustainability.
U.Va. researchers identify that HIV drugs can protect against Alzheimer’s disease
By Lauren Seeliger | May 22, 2025Doctor Jayakrishna Ambati and his research team have begun work on a new drug called K9 which could treat and prevent Alzheimer’s.
